PI
AMRX icon

Putnam Investments’s Amneal Pharmaceuticals AMRX Stock Holding History

Putnam Investments’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$422K Sell
69,593
-83,028
-54% -$370K ﹤0.01% 976
2023
Q3 		$644K Buy
+152,621
New +$569K ﹤0.01% 891

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Putnam Investments's AMRX Position: Q4 2023 in Review

Putnam Investments reduced its Amneal Pharmaceuticals (AMRX) stake by 54% in Q4 2023, selling an estimated $370K and leaving 69,593 shares worth $422K. The position accounts for ﹤0.01% of the portfolio, ranked #976.

Putnam Investments first reported a position in AMRX in Q3 2023 and has held it in 2 quarters since. The position peaked at $644K in Q3 2023. 153 funds tracked by Wall St. Rank hold AMRX as of Q4 2023.

  • Putnam Investments held 69,593 shares of Amneal Pharmaceuticals worth $422K as of Q4 2023.
  • Putnam Investments sold 83,028 Amneal Pharmaceuticals shares in Q4 2023, an estimated $370K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #976 holding.
  • Putnam Investments first reported a position in Amneal Pharmaceuticals in Q3 2023 and has held it in 2 quarters since.
  • Putnam Investments's Amneal Pharmaceuticals position peaked at $644K in Q3 2023.
  • 153 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.